DE69927985D1 - Verwendung von misoprostol oder/und misoprostol saüre zur herstellung eines arzneimittels zur behandlung weiblicher sexualer störung - Google Patents

Verwendung von misoprostol oder/und misoprostol saüre zur herstellung eines arzneimittels zur behandlung weiblicher sexualer störung

Info

Publication number
DE69927985D1
DE69927985D1 DE69927985T DE69927985T DE69927985D1 DE 69927985 D1 DE69927985 D1 DE 69927985D1 DE 69927985 T DE69927985 T DE 69927985T DE 69927985 T DE69927985 T DE 69927985T DE 69927985 D1 DE69927985 D1 DE 69927985D1
Authority
DE
Germany
Prior art keywords
misoprostol
medicament
manufacture
treatment
female sexual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69927985T
Other languages
English (en)
Other versions
DE69927985T2 (de
Inventor
Petros Karouzakis
Panagiotis Kanakaris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69927985D1 publication Critical patent/DE69927985D1/de
Application granted granted Critical
Publication of DE69927985T2 publication Critical patent/DE69927985T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69927985T 1998-08-14 1999-08-13 Verwendung von misoprostol oder/und misoprostol saüre zur herstellung eines arzneimittels zur behandlung weiblicher sexualer störung Expired - Fee Related DE69927985T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GR98100315 1998-08-14
GR98100315 1998-08-14
PCT/GR1999/000030 WO2000009134A1 (en) 1998-08-14 1999-08-13 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure sexual dysfunction in women

Publications (2)

Publication Number Publication Date
DE69927985D1 true DE69927985D1 (de) 2005-12-01
DE69927985T2 DE69927985T2 (de) 2006-07-27

Family

ID=10943471

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69927985T Expired - Fee Related DE69927985T2 (de) 1998-08-14 1999-08-13 Verwendung von misoprostol oder/und misoprostol saüre zur herstellung eines arzneimittels zur behandlung weiblicher sexualer störung

Country Status (9)

Country Link
US (1) US6897239B1 (de)
EP (1) EP1107762B9 (de)
JP (1) JP2002522500A (de)
AT (1) ATE307590T1 (de)
AU (1) AU5186299A (de)
DE (1) DE69927985T2 (de)
ES (1) ES2249906T3 (de)
GR (1) GR1003199B (de)
WO (1) WO2000009134A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106667900A (zh) * 2017-01-24 2017-05-17 楚雄医药高等专科学校 一种具有生物粘附和良好生物相容性的凝胶基质及其制备方法与应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
US5242391A (en) 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
US5962528A (en) 1991-07-03 1999-10-05 Scott; Nathan Earl Prostaglandin E2 /F2α combination for treating impotence
WO1993000894A1 (en) 1991-07-03 1993-01-21 Scott Nathan E Prostaglandin e2 treatment of impotence
US5252602A (en) 1991-10-11 1993-10-12 Rafeul Alam Effects of misoprostol on allergic responses
US5773457A (en) 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
BR9203277A (pt) 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
US5324746A (en) 1993-02-12 1994-06-28 Mckee Rex N Method of treating damaged mucosal and epithelial tissues with misoprostol
US5612359A (en) 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
GB9419566D0 (en) 1994-09-27 1994-11-16 El Refaey Hazem Oral prostagladins for the routine management of the third stage of labour
BR9607365A (pt) 1995-03-14 1997-12-30 Vivus Inc Processo e kit para prevenir disfunção de ereção
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US5688499A (en) 1996-03-13 1997-11-18 Queen's University At Kingston Antagonism of endothelin actions
US5684177A (en) 1996-05-17 1997-11-04 Torcan Chemical Ltd. Misoprostol
GR1002847B (el) 1997-05-06 1998-01-27 Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως
US6103765A (en) * 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
US6593369B2 (en) 1997-10-20 2003-07-15 Vivus, Inc. Methods, compositions, and kits for enhancing female sexual desire and responsiveness
US5877216A (en) 1997-10-28 1999-03-02 Vivus, Incorporated Treatment of female sexual dysfunction
AU740758B2 (en) 1997-10-28 2001-11-15 Vivus, Inc. Treatment of female sexual dysfunction
US6046244A (en) * 1997-11-05 2000-04-04 Nexmed Holdings, Inc. Topical compositions for prostaglandin E1 delivery
US6046240A (en) 1998-05-01 2000-04-04 Harvard Scientific Corporation Methods for treating female sexual dysfunction
US6277884B1 (en) 1998-06-01 2001-08-21 Nitromed, Inc. Treatment of sexual dysfunction with N-hydroxyguanidine compounds
US5942545A (en) 1998-06-15 1999-08-24 Macrochem Corporation Composition and method for treating penile erectile dysfunction
CA2353613A1 (en) 1998-12-02 2000-06-08 Shigeharu Suzuki Preparations for intraurethral administration
IL139941A0 (en) 1999-12-02 2002-02-10 Pfizer Prod Inc Use of prostaglandin agonists to treat erectile dysfunction or impotence
JP2003528088A (ja) 2000-03-23 2003-09-24 メルク エンド カムパニー インコーポレーテッド メラノコルチン受容体作働薬としての置換ピペリジン類
AU2001249281B2 (en) 2000-03-23 2005-01-27 Merck & Co., Inc. Spiropiperidine derivatives as melanocortin receptor agonists
US6476037B1 (en) 2000-03-23 2002-11-05 The Regents Of The University Of California L-arginine and phosphodiesterase (PDE) inhibitor synergism

Also Published As

Publication number Publication date
WO2000009134A1 (en) 2000-02-24
GR1003199B (el) 1999-09-01
ATE307590T1 (de) 2005-11-15
EP1107762B1 (de) 2005-10-26
EP1107762B9 (de) 2006-08-16
JP2002522500A (ja) 2002-07-23
DE69927985T2 (de) 2006-07-27
ES2249906T3 (es) 2006-04-01
EP1107762A1 (de) 2001-06-20
US6897239B1 (en) 2005-05-24
AU5186299A (en) 2000-03-06

Similar Documents

Publication Publication Date Title
ATE252359T1 (de) Therapiebandage
PT880350E (pt) Tratamento de esclerose multipla
ATE321548T1 (de) Verwendung von statin zur behandlung von hauterkrankungen
ATE289508T1 (de) Butyrate derivaten zur behandlung von fibromyalgia und chronische müdigkeit-syndrom
DE60115000D1 (de) Die Verwendung von Prostaglandin F Analoga zur Herstellung von Zusammensetzungen für die Behandlung von Haarausfall.
DE69634900D1 (de) Proteintyrosine-kinaseinhibitoren zur behandlung der osteoarthritis
DE69613840T2 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ATE365042T1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
BRPI0006634B8 (pt) composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios
ATE510551T1 (de) Hemmung von gs-fdh zur modulierung der no- bioaktivität
DE60212613D1 (de) Doxycyclin zur behandlung von akne
ATE296098T1 (de) Verwendung von topiramat zur behandlung und diagnostizierung von atemstörungen während des schlafens und mittel zur durchführung der behandlung und diagnose
DE69512760T2 (de) Verwendung von Melatonin zur Behandlung von Patienten die an Drogenabhängigkeit leiden
DE69902520D1 (de) Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
DE69829202D1 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
SE9601395D0 (sv) New therapeutic treatment 1
DE60030107D1 (de) Vitamin-d derivate zur behandlung des systemischen lupus erythematodes
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
DE69927985D1 (de) Verwendung von misoprostol oder/und misoprostol saüre zur herstellung eines arzneimittels zur behandlung weiblicher sexualer störung
ATE293972T1 (de) Behandlung von chronischen schmerzen
DE69627298D1 (de) Verwendung von sklareolide für die behandlung von excessiven zellwachstumskrankheiten
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы
ATE369143T1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
ATE458495T1 (de) Therapeutische zubereitung für autoimmune erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee